A5033400365- Glioma Diagnosis and Treatment
- Brain Metastases and Treatment
- Endometrial and Cervical Cancer Treatments
- Erythropoietin and Anemia Treatment
- Mathematical Biology Tumor Growth
- Head and Neck Surgical Oncology
- Ovarian cancer diagnosis and treatment
- Pharmacological Effects and Toxicity Studies
- Head and Neck Cancer Studies
- Digital Radiography and Breast Imaging
- Lung Cancer Treatments and Mutations
- Cancer-related Molecular Pathways
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Uterine Myomas and Treatments
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
- Breast Cancer Treatment Studies
- Breast Implant and Reconstruction
- Lung Cancer Diagnosis and Treatment
- Blood transfusion and management
- Multiple and Secondary Primary Cancers
- Colorectal Cancer Treatments and Studies
- Colorectal and Anal Carcinomas
- RNA modifications and cancer
- Cancer, Hypoxia, and Metabolism
Aristotle University of Thessaloniki
2011-2024
AHEPA University Hospital
2024
Interbalkan Medical Center
2024
St Savas Hospital
2024
Theageneio General Hospital
2024
St. Luke's Hospital
2023
Papageorgiou General Hospital
2004-2011
Hellenic Cooperative Oncology Group
2010
Hellenic Oncology Research Group
2005
Hippocampus protection, as an organ at risk in brain radiotherapy, might protect patients' quality of life. Prophylactic cranial irradiation (PCI) has been used traditionally small cell lung cancer (SCLC) patients it increases survival. This study aimed to discover the contributing parameters for a successful PCI with simultaneous protection hippocampus by using three different treatment machines. For this purpose, plans were generated 45 SCLC half-arcs linear accelerators (LINACs; Elekta...
Local recurrence rate may show no significant differences between women aged 60 and older who receive breast-conserving surgery followed by radiotherapy those in the same age group undergo without subsequent radiotherapy.
Abstract The anti-EGFR antibody cetuximab (Erbitux®, CTX) has been introduced into clinical practice for the treatment of SCCHN, as yet with modest effectiveness. Src family targeting agents have shown anti-growth activity in SCCHN preclinical models and are currently considered further exploration same tumor system. In this study we investigated expression activation SRC/STAT pathway components order to assess how they related already use upcoming, targeted modalities. Relative SRC, STATs...
18531 Background: Anaemia is a poor prognostic factor for patients undergoing radiotherapy (XRT) and has been associated with decreased response to treatment. Darbepoetin alfa proven effective in treating anaemia improving QoL. The purpose of this study was assess the efficacy, safety impact on QoL darbepoetin these pts. Methods: Patients Hb level 10–12 g/dl, PS ECOG <2, life expectancy >6 mos were administered SC 150 mcg once weekly during 6 wk course conventional XRT (2 Gy/5...